Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
57.89 USD | -6.78% | -11.01% | -30.66% |
May. 09 | Oppenheimer Adjusts Cytokinetics Price Target to $106 From $107, Maintains Outperform Rating | MT |
May. 08 | Cytokinetics Q1 Net Loss Narrows, Revenue Declines | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.66% | 6.07B | |
+5.66% | 111B | |
+11.23% | 105B | |
-2.85% | 21.93B | |
-12.15% | 22.34B | |
-5.29% | 18.59B | |
-36.52% | 18.12B | |
-10.09% | 16.96B | |
+3.33% | 13.7B | |
+36.58% | 12.45B |
- Stock Market
- Equities
- CYTK Stock
- News Cytokinetics, Incorporated
- Needham Cuts Price Target on Cytokinetics to $58 From $60, Keeps Buy Rating